Your browser doesn't support javascript.
loading
Adalimumab versus adalimumab and methotrexate for the treatment of juvenile idiopathic arthritis: long-term data from the German BIKER registry.
Klein, A; Becker, I; Minden, K; Foeldvari, I; Haas, J P; Horneff, G.
Affiliation
  • Klein A; a Department of Paediatrics , Centre for Paediatric Rheumatology, Asklepios Clinic Sankt Augustin , Sankt Augustin , Germany.
  • Becker I; b Medical Faculty , University of Cologne , Cologne , Germany.
  • Minden K; c Institute of Medical Statistics and Computational Biology , University of Cologne , Cologne , Germany.
  • Foeldvari I; d German Rheumatism Research Centre Berlin, and Charité University Medicine , Berlin , Germany.
  • Haas JP; e Hamburg Centre of Paediatric and Adolescent Rheumatology , Hamburg , Germany.
  • Horneff G; f German Centre for Paediatric and Adolescent Rheumatology , Garmisch-Partenkirchen , Germany.
Scand J Rheumatol ; 48(2): 95-104, 2019 Mar.
Article in En | MEDLINE | ID: mdl-30411654
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Registries / Methotrexate / Antirheumatic Agents / Adalimumab Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male / Pregnancy Language: En Journal: Scand J Rheumatol Year: 2019 Document type: Article
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Arthritis, Juvenile / Registries / Methotrexate / Antirheumatic Agents / Adalimumab Type of study: Observational_studies / Risk_factors_studies Limits: Adolescent / Child / Female / Humans / Male / Pregnancy Language: En Journal: Scand J Rheumatol Year: 2019 Document type: Article